Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study

QR Code

Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study

Introduction: Heart failure (HF) is frequently associated with multiple cardiac and noncardiac comorbidities, with most requiring active management. Various studies using multiple tools iterate the association between various components of quality of life (QoL) in HF patients. Identifying comorbidit...

Full description

Saved in:

Bibliographic Details
Main Authors:	J. Anusha, Vishwanath Krishnamurthy, Varun V. Prakash, Madhu P. Raj, H. Aadithya Shyllesh, G.R. Bharath
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	APIK Journal of Internal Medicine
Subjects:	heart failure heart failure with preserved ejection fraction heart failure with reduced ejection fraction kansas city cardiomyopathy questionnaire
Online Access:	https://journals.lww.com/10.4103/ajim.ajim_8_25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi‐Ethnic Study of Atherosclerosis: The Pooling Project
by: Sarah Nomura, et al.
Published: (2025-06-01)

Biomarkers in the Pathogenesis of Heart Failure with Preserved as Well as Reduced Ejection Fraction: A Cross-sectional Study
by: Sowmiya Thiyagarajan, et al.
Published: (2025-06-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)

Effect of dapagliflozin in paroxysmal atrial fibrillation combined with heart failure with preserved ejection fraction: a randomized controlled trial
by: Xiaoyu LIAN, et al.
Published: (2025-06-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

The impact of glomerular filtration rate on short-term outcome in elderly patients with heart failure with preserved ejection fraction
by: Giuseppe Delli Carpini, et al.
Published: (2025-07-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)

Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)

Clinical and prognostic value of determining the level of neopterin in patients with chronic heart failure with preserved ejection fraction
by: O. S. Polunina, et al.
Published: (2018-10-01)

Results of the Russian Society of Cardiology survey "Chronic heart failure. Unsolved issues"
by: O. B. Irtyuga, et al.
Published: (2024-06-01)

Features of chronic heart failure depending on the left ventricular ejection fraction
by: A. G. Dushina, et al.
Published: (2019-03-01)

About the classification of heart failure
by: A. S. Galyavich, et al.
Published: (2023-09-01)

Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
by: M. A. Vander, et al.
Published: (2021-02-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)

Chronic Heart Failure with Preserved Ejection Fraction in A Comorbid Patient: Issues in Verification of A «Difficult» Diagnosis
by: O. V. Ponomareva, et al.
Published: (2025-05-01)

The Physical Activity in the Management of Heart Failure with Reduced Ejection Fraction A Review of Current Evidence and Recommendations
by: Natalia Smyl, et al.
Published: (2025-07-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease
by: O. A. Osipova, et al.
Published: (2020-11-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)

Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
by: Zh. D. Kobalava, et al.
Published: (2023-02-01)

PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01)

Microcirculation in heart failure: state of the art (literature review)
by: I. M. Davidovich, et al.
Published: (2025-02-01)

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
by: A. A. Shchendrygina, et al.
Published: (2021-07-01)

A two‐phase approach to identifying HFpEF in heart failure patients: Risk score evaluation and decision tree development
by: Izabella Uchmanowicz, et al.
Published: (2025-08-01)

Analysis of echocardiographic parameters suggestive of pulmonary hypertension in patients with heart failure with preserved ejection fraction and assessment of clinical features favoring development of the PH-phenotype
by: Julia Dołęga, et al.
Published: (2025-04-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect
by: M. T. Duishenalieva, et al.
Published: (2025-05-01)

Diastolic heart failure: boundaries of term application
by: V. V. Kalyuzhin, et al.
Published: (2023-04-01)

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report
by: E. A. Pravkina, et al.
Published: (2023-07-01)

Lost Rate Control and Tachycardia-Induced Cardiomyopathy as a Result of an Interaction Between Enzalutamide and Diltiazem
by: Adrian de Boer, PharmD, et al.
Published: (2025-07-01)

Características clínicas y tratamiento farmacológico de los pacientes con insuficiencia cardíaca en una cohorte de atención primaria
by: Maria Giner-Soriano, et al.
Published: (2025-07-01)

Significance of catestatin in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2023-11-01)